CAHP-210 dialyzer influence on intra-dialytic vancomycin removal

Nephrology Dialysis Transplantation

Volumn 17, Issue 9, 2002, Pages 1649-1654

  Lucksiri, Aroonrut ^a   Scott, Meri K ^a   Mueller, Bruce A ^a,c   Hamburger, Richard J ^b   Sowinski, Kevin M ^a  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Antibiotics; Biocompatible membrane; Cellulose acetate; Cellulose acetate high performance 210; Cross over study; Drug removal; End stage renal disease; Glycopeptide; Haemodialysis; Hemodialyzer; Human; Pharmacokinetics; Prospective study; Vancomycin

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG ELIMINATION; DRUG EXPOSURE; DRUG INFUSION; FEMALE; HEMODIALYSIS; HUMAN; IMMUNOASSAY; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0036713043     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.9.1649     Document Type: Article

References (18)

1. USRDS 2001 annual data report: Atlas of end-stage renal disease in the United States
2. Bacteremia associated with tunneled, cuffed hemodialysis catheters
3. Outcome and complications of temporary haemodialysis catheters
4. Vancomycin elimination during high-flux hemodialysis: Kinetic model and comparison of four membranes
5. In vivo comparison of three different hemodialysis membranes for vancomycin clearance: Cuprophan, cellulose acetate, and polyacrylonitrile
6. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile
7. Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers
8. Effects of dialysis membrane on intradialytic vancomycin administration
9. Pharmacokinetics of vancomycin when administered during high-flux hemodialysis
10. Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease
11. Vancomycin redistribution: Dosing recommendations following high-flux hemodialysis
12. Cellulose acetate hollow fiber dialyzer
13. The effects of peracetic acid-hydrogen peroxide reprocessing on dialyzer solute and water permeability
14. Dialyzer-dependent changes in solute and water permeability with bleach reprocessing
15. ADAPT II User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software
16. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis
17. Pharmacokinetics
18. Performance Standards, for Antimicrobial Susceptibility Testing: M100-S10 (M7)